Financial Graphs

"BMB has its optics focused on challenging the current standard-of-care implantable metal fixators for fracture treatments. As no competitive technology exists on the market, BMB’s Bonevolent™ platform will be the first mover by providing patient-personalized composite-based fixators that enhances the patient’s ability to recover, independent if it is for human or animal wellbeing."

Michael Malkoch
Founder and CEO
Earth

the markets

the markets

The market ny_edited.jpg
Meeting

why invest

why invest

Why invest ny_edited.jpg